| Filed On | Filing |
|---|---|
| 02 Oct 2025 |
8-K/A: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation
1167 Massachusetts Ave., Arlington, MA 02476 · Tel 781.996.5252 · Fax 781.642.0399 · www.kalarx.com |
| 12 Jul 2022 |
8-K/A: Financial Statements and Exhibits
On July 8, 2022 (the “Closing Date”), Kala Pharmaceuticals, Inc. (“Kala”, the “Company” “we” or “us”) completed the previously announced transaction (the “Transaction”), pursuant to which, Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC... |
| 28 Jan 2022 |
8-K/A: Financial Statements and Exhibits
As of September 30, 2021 and for the Nine Months Then Ended, and |
Loading...